- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 42
Introduction: Incidence of C.difficile Infection (CDI)
Background: Characteristics of Osteoarthritis
Presentation: Analgesics for Osteoarthritis—An Update
Keywords: background | prevalence | characteristics
Applicability Resources
Presentation: Assessing Applicability
Background: Epidemiology of Obstructive Sleep Apnea
Keywords: symptoms | prevalence | background | epidemiology | public health
Other Findings: Influence of Patient Characteristics on Outcomes of DMARD Treatment
Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: adverse effects | anakinra | anti-rheumatic | antirheumatic | biologic DMARD | cardiovascular event | comorbidities | disease-modifying | DMARDs | methotrexate | methotrexate | oral DMARD | RA | renal impairment | rheumatoid arthritis
Knowledge Gaps and Future Research Needs (1 of 3)
Summary of Study Characteristics Evaluated in the CER: The PICOTS Framework
Presentation: Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
Keywords: adverse effects | comparators | mixed incontinence | outcomes | PICOTS | population | quality of life | setting | severity | stress incontinence | timing | urge incontinence | urgency incontinence | uinary incontinence
Conclusions About Benefits and Adverse Effects (2 of 2)
Clinical Questions Addressed by the CER (4 of 4)
Adverse Effects of Interest in the Comparative Effectiveness Review
Presentation: Off-Label Use of Atypical Antipsychotics: An Update
Keywords: adverse events | atypical antipsychotics | cardiovascular events | diabetes | elderly | endocrine | extrapyramidal symptoms | mortality | off-label | second generation | sedation | weight | antipsychotics
Your slide tray is being processed.